Recombinant Capital's Breakthrough Alliance Award for 2006
Today Recombinant Capital has announced its nominees for the 11th Annual Breakthrough Alliance Award.
This makes for another third party source of the most important alliances of 2006. Recombinant Capital's nominees are:
This makes for another third party source of the most important alliances of 2006. Recombinant Capital's nominees are:
- GSK Epix Drug Discovery and Co-Development Alliance of 12/06 (not yet disclosed)
- Janssen Vertex Co-Development Agreement of 6/06
- MedImmune Infinity Co-Development and Commercialization Alliance of 8/06
- Novartis Human Genome Sciences Co-Development Agreement of 6/06
- Takeda Affymax Co-Development Agreement of 6/06
0 Comments:
Post a Comment
Links to this post:
Create a Link
<< Home